Global Budesonide Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Big Is the Budesonide Market Size Expected to Be by 2034?
In recent years, the budesonide market has experienced robust growth. It is anticipated to expand from $9.72 billion in 2024 to $10.36 billion in 2025, with 6.6% compound annual growth rate (CAGR). The growth experienced in the past owes much to a rise in respiratory diseases, heightened awareness about inhaled corticosteroids, new combination therapies that use budesonide, greater access to healTH*Care and improvements in healTH*Care infrastructure, and the application of budesonide in unapproved usage areas such as inflammatory bowel diseases.

The budesonide market is projected to experience robust growth in the forTH*Coming years. It's anticipated to reach a value of $13.25 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. This growth, expected over the forecast period, is attributed to the increasing demand for effective treatments, the creation of innovative drug delivery systems, a rise in budesonide usage, an aging populace susceptible to asthma, and the growth of generic budesonide products. Key trends over this forecast period include the adoption and advancement of biologics and biosimilars, regulatory sanctions for new formulations, the creation of novel drug delivery systems, and tech advancements.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21121

What Are the Emerging Segments Within the Budesonide Market?
The budesonide market covered in this report is segmented -

1) By Type: Inhalation Powder, Aerosols, Injectable Suspension, Tablets And Capsules
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications

Subsegments:
1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)
2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers
3) By Injectable Suspension: Pre-filled Syringes, Vials
4) By Tablets And Capsules: Oral Tablets, Oral Capsules

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp

What Long-Term Drivers Are Shaping Budesonide Market Trends?
The rising prevalence of respiratory ailments is predicted to fuel the expansion of the budesonide market. Respiratory ailments are health conditions that affect the tissues and organs involved in the gas exchange process in air-breathing creatures. The mounting prevalence of these diseases can be attributed to escalating air pollution, especially from particulate matter and allergens, that profoundly affect the occurrence of asthma and chronic obstructive lung disease. Budesonide is used in treating respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), as it can reduce inflammation, enhance airflow, and prevent symptoms like wheezing or short breath. For example, the National Center for Health Statistics (NCHS), a health statistics agency based in the U.S., reported in May 2024, that the prevalence of current asthma in adults above 18 years of age in the United States rose from 8.4% in 2021 to 8.7% in 2022. Also, the instances of asthma episodes in the preceding 12 months for adults in the same age bracket increased from 3.3% in 2021 to 3.7% in 2022. Thus, the escalating prevalence of respiratory diseases is projected to steer the growth of the budesonide market.

Who Are the Top Competitors in Key Budesonide Market Segments?
Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd.

What Are the Latest Developing Trends in the Budesonide Market?
Main players in the budesonide industry are advancing their focus on improvements in treatments for respiratory disorders such as oral therapy, enhancing patient usability, increasing therapy compliance, and widening their range of therapeutic options for conditions like asthma and other respiratory disorders. Budesonide oral therapy, primarily used for managing inflammatory conditions, is a version of budesonide that's taken orally. As an illustration, Takeda Pharmaceuticals, a firm based in Japan, revealed in February 2024 that the U.S. Food and Drug Administration (FDA) granted approval for EOHILIA, an oral budesonide suspension, making it the first and sole FDA-approved oral drug for patients 11 years and older diagnosed with eosinophilic esophagitis (EoE). Moreover, the FDA approved EOHILIA with a dosage of 2 mg twice daily, based on effectiveness and safety outcomes from two multicenter, randomized, double-blind, parallel-group, placebo-controlled studies conducted over 12 weeks on individuals aged 11 to 56 suffering from EoE.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report

Which Regions Are Becoming Hubs for Budesonide Market Innovation?
North America was the largest region in the budesonide market in 2024. The regions covered in the budesonide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Budesonide Market?
2. What is the CAGR expected in the Budesonide Market?
3. What Are the Key Innovations Transforming the Budesonide Industry?
4. Which Region Is Leading the Budesonide Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.